Tianjin Life Science & Technology Pharmaceutical Co., Ltd. announced that its Dexamethasone Acetate Tablets (0.75mg) have passed the generic drug consistency evaluation. This achievement is expected to enhance the product's market competitiveness. The company cautions investors about potential uncertainties in sales due to market dynamics.
Summary generated by AI · Always verify with source document
The company and all members of the board of directors guarantee the truthfulness, accuracy, and completeness of the information disclosed, and that there are no false records, misleading statements, or major omissions.
Sign in to read the full translation
Free accounts get 10 full releases per month. Pro subscribers get unlimited access.